Malignant Neoplasms of Ill-defined Secondary and Unspecified Sites
📧 Sign up to get email alerts when something new happens for Malignant Neoplasms of Ill-defined Secondary and Unspecified Sites.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2022-12-16Clinical Trial Update: Utomilumab and ISA101b Vaccination in Patients With HPV-16-Positive Incurable Oropharyngeal Cancer [Phase 2]
Phase 2 trial investigating utomilumab and ISA101b vaccination in HPV-16–positive incurable oropharyngeal cancer; the study was terminated w…